APO Research
Talk to an analyst

APO RESEARCH · REPORT

Automatic Insulin Dosing Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Automatic Insulin Dosing Device Industry Research Report 2026

4 July 2026121 pages

Choose your research edition.

Industry ResearchAutomatic Insulin Dosing Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Automatic Insulin Dosing Device Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Automatic Insulin Dosing Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Automatic Insulin Dosing Device Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Automatic Insulin Dosing Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Automatic Insulin Dosing Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Automatic Insulin Dosing Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Automatic Insulin Dosing Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Automatic Insulin Dosing Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Automatic Insulin Dosing Device include Admetsys, Beta Bionics, Bigfoot Biomedical, Defymed, Dexcom, Insulet, Micro Tech Medical, Tandem Diabetes Care and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Automatic Insulin Dosing Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Automatic Insulin Dosing Device Market by Company

Admetsys

Beta Bionics

Bigfoot Biomedical

Defymed

Dexcom

Insulet

Micro Tech Medical

Tandem Diabetes Care

Medtronic

Abbott

Automatic Insulin Dosing Device Segment by Type

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other

Automatic Insulin Dosing Device Segment by Application

Hospital

Clinic

Home Care

Others

Automatic Insulin Dosing Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dosing Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dosing Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dosing Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Automatic Insulin Dosing Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Automatic Insulin Dosing Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Automatic Insulin Dosing Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Automatic Insulin Dosing Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Automatic Insulin Dosing Device Sales (k units) of Manufacturers (2021-2026) Table 7. Global Automatic Insulin Dosing Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Automatic Insulin Dosing Device Revenue of Manufacturers (2021-2026) Table 9. Global Automatic Insulin Dosing Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Automatic Insulin Dosing Device Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Automatic Insulin Dosing Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Automatic Insulin Dosing Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Automatic Insulin Dosing Device, Product Type & Application Table 14. Global Automatic Insulin Dosing Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Automatic Insulin Dosing Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Admetsys Company Information Table 19. Admetsys Business Overview Table 20. Admetsys Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Admetsys Automatic Insulin Dosing Device Product Portfolio Table 22. Admetsys Recent Developments Table 23. Beta Bionics Company Information Table 24. Beta Bionics Business Overview Table 25. Beta Bionics Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Beta Bionics Automatic Insulin Dosing Device Product Portfolio Table 27. Beta Bionics Recent Developments Table 28. Bigfoot Biomedical Company Information Table 29. Bigfoot Biomedical Business Overview Table 30. Bigfoot Biomedical Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio Table 32. Bigfoot Biomedical Recent Developments Table 33. Defymed Company Information Table 34. Defymed Business Overview Table 35. Defymed Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Defymed Automatic Insulin Dosing Device Product Portfolio Table 37. Defymed Recent Developments Table 38. Dexcom Company Information Table 39. Dexcom Business Overview Table 40. Dexcom Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Dexcom Automatic Insulin Dosing Device Product Portfolio Table 42. Dexcom Recent Developments Table 43. Insulet Company Information Table 44. Insulet Business Overview Table 45. Insulet Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Insulet Automatic Insulin Dosing Device Product Portfolio Table 47. Insulet Recent Developments Table 48. Micro Tech Medical Company Information Table 49. Micro Tech Medical Business Overview Table 50. Micro Tech Medical Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio Table 52. Micro Tech Medical Recent Developments Table 53. Tandem Diabetes Care Company Information Table 54. Tandem Diabetes Care Business Overview Table 55. Tandem Diabetes Care Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio Table 57. Tandem Diabetes Care Recent Developments Table 58. Medtronic Company Information Table 59. Medtronic Business Overview Table 60. Medtronic Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Medtronic Automatic Insulin Dosing Device Product Portfolio Table 62. Medtronic Recent Developments Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Automatic Insulin Dosing Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Abbott Automatic Insulin Dosing Device Product Portfolio Table 67. Abbott Recent Developments Table 68. Global Automatic Insulin Dosing Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Automatic Insulin Dosing Device Sales by Region (2021-2026) & (k units) Table 70. Global Automatic Insulin Dosing Device Sales Market Share by Region (2021-2026) Table 71. Global Automatic Insulin Dosing Device Sales by Region (2027-2032) & (k units) Table 72. Global Automatic Insulin Dosing Device Sales Market Share by Region (2027-2032) Table 73. Global Automatic Insulin Dosing Device Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Automatic Insulin Dosing Device Revenue Market Share by Region (2021-2026) Table 75. Global Automatic Insulin Dosing Device Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Automatic Insulin Dosing Device Revenue Market Share by Region (2027-2032) Table 77. North America Automatic Insulin Dosing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 79. North America Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 80. North America Automatic Insulin Dosing Device Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Automatic Insulin Dosing Device Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Automatic Insulin Dosing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 84. Europe Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 85. Europe Automatic Insulin Dosing Device Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Automatic Insulin Dosing Device Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Automatic Insulin Dosing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 89. Asia Pacific Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 90. Asia Pacific Automatic Insulin Dosing Device Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Automatic Insulin Dosing Device Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Automatic Insulin Dosing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 94. South America Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 95. South America Automatic Insulin Dosing Device Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Automatic Insulin Dosing Device Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Automatic Insulin Dosing Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2026) & (k units) Table 99. Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2027-2032) & (k units) Table 100. Middle East and Africa Automatic Insulin Dosing Device Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Automatic Insulin Dosing Device Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Automatic Insulin Dosing Device Sales by Type (2021-2026) & (k units) Table 103. Global Automatic Insulin Dosing Device Sales by Type (2027-2032) & (k units) Table 104. Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2026) Table 105. Global Automatic Insulin Dosing Device Sales Market Share by Type (2027-2032) Table 106. Global Automatic Insulin Dosing Device Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Automatic Insulin Dosing Device Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2026) Table 109. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2027-2032) Table 110. Global Automatic Insulin Dosing Device Price by Type (2021-2026) & (USD/unit) Table 111. Global Automatic Insulin Dosing Device Price by Type (2027-2032) & (USD/unit) Table 112. Global Automatic Insulin Dosing Device Sales by Application (2021-2026) & (k units) Table 113. Global Automatic Insulin Dosing Device Sales by Application (2027-2032) & (k units) Table 114. Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2026) Table 115. Global Automatic Insulin Dosing Device Sales Market Share by Application (2027-2032) Table 116. Global Automatic Insulin Dosing Device Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Automatic Insulin Dosing Device Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2026) Table 119. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2027-2032) Table 120. Global Automatic Insulin Dosing Device Price by Application (2021-2026) & (USD/unit) Table 121. Global Automatic Insulin Dosing Device Price by Application (2027-2032) & (USD/unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Automatic Insulin Dosing Device Distributors List Table 125. Automatic Insulin Dosing Device Customers List Table 126. Automatic Insulin Dosing Device Industry Trends Table 127. Automatic Insulin Dosing Device Industry Drivers Table 128. Automatic Insulin Dosing Device Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Automatic Insulin Dosing Device Product Image Figure 5. Global Automatic Insulin Dosing Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Automatic Insulin Dosing Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Automatic Insulin Dosing Device Sales (2021-2032) & (k units) Figure 8. Global Automatic Insulin Dosing Device Average Price (USD/unit) & (2021-2032) Figure 9. Threshold Suspended Device Systems Product Image Figure 10. Hybrid Closed-loop APDS Product Image Figure 11. Other Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Home Care Product Image Figure 15. Others Product Image Figure 16. Global Automatic Insulin Dosing Device Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Automatic Insulin Dosing Device, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Automatic Insulin Dosing Device Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Automatic Insulin Dosing Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Automatic Insulin Dosing Device Sales by Region in 2025 Figure 22. Global Automatic Insulin Dosing Device Revenue by Region in 2025 Figure 23. North America Automatic Insulin Dosing Device Market Size by Country in 2025 Figure 24. North America Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 25. North America Automatic Insulin Dosing Device Revenue Market Share by Country (2021-2032) Figure 26. United States Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Automatic Insulin Dosing Device Market Size by Country in 2025 Figure 30. Europe Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 31. Europe Automatic Insulin Dosing Device Revenue Market Share by Country (2021-2032) Figure 32. Germany Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Automatic Insulin Dosing Device Market Size by Country in 2025 Figure 43. Asia Pacific Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Automatic Insulin Dosing Device Revenue Market Share by Country (2021-2032) Figure 45. China Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Automatic Insulin Dosing Device Market Size by Country in 2025 Figure 54. South America Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 55. South America Automatic Insulin Dosing Device Revenue Market Share by Country (2021-2032) Figure 56. Brazil Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Automatic Insulin Dosing Device Market Size by Country in 2025 Figure 60. Middle East and Africa Automatic Insulin Dosing Device Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Automatic Insulin Dosing Device Revenue Market Share by Country (2021-2032) Figure 62. Egypt Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Automatic Insulin Dosing Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2032) Figure 68. Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2032) Figure 69. Global Automatic Insulin Dosing Device Price (USD/unit) by Type (2021-2032) Figure 70. Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2032) Figure 71. Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2032) Figure 72. Global Automatic Insulin Dosing Device Price (USD/unit) by Application (2021-2032) Figure 73. Automatic Insulin Dosing Device Value Chain Figure 74. Automatic Insulin Dosing Device Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Automatic Insulin Dosing Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other
Applications
  • Hospital
  • Clinic
  • Home Care
  • Others
Companies covered
  • Admetsys
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Dexcom
  • Insulet
  • Micro Tech Medical
  • Tandem Diabetes Care
  • Medtronic
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Automatic Insulin Dosing Device Market Size (2021-2032)
  4. 2.2.2 Global Automatic Insulin Dosing Device Sales (2021-2032)
  5. 2.2.3 Global Automatic Insulin Dosing Device Market Average Price (2021-2032)
  6. 2.3 Automatic Insulin Dosing Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Threshold Suspended Device Systems
  9. 2.3.3 Hybrid Closed-loop APDS
  10. 2.3.4 Other
  11. 2.4 Automatic Insulin Dosing Device by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Home Care
  16. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Automatic Insulin Dosing Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Automatic Insulin Dosing Device Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Automatic Insulin Dosing Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Automatic Insulin Dosing Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Automatic Insulin Dosing Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Automatic Insulin Dosing Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Automatic Insulin Dosing Device, Product Type & Application
  8. 3.8 Global Manufacturers of Automatic Insulin Dosing Device, Established Date
  9. 3.9 Global Automatic Insulin Dosing Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Admetsys
  2. 4.1.1 Admetsys Company Information
  3. 4.1.2 Admetsys Business Overview
  4. 4.1.3 Admetsys Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Admetsys Automatic Insulin Dosing Device Product Portfolio
  6. 4.1.5 Admetsys Recent Developments
  7. 4.2 Beta Bionics
  8. 4.2.1 Beta Bionics Company Information
  9. 4.2.2 Beta Bionics Business Overview
  10. 4.2.3 Beta Bionics Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Beta Bionics Automatic Insulin Dosing Device Product Portfolio
  12. 4.2.5 Beta Bionics Recent Developments
  13. 4.3 Bigfoot Biomedical
  14. 4.3.1 Bigfoot Biomedical Company Information
  15. 4.3.2 Bigfoot Biomedical Business Overview
  16. 4.3.3 Bigfoot Biomedical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bigfoot Biomedical Automatic Insulin Dosing Device Product Portfolio
  18. 4.3.5 Bigfoot Biomedical Recent Developments
  19. 4.4 Defymed
  20. 4.4.1 Defymed Company Information
  21. 4.4.2 Defymed Business Overview
  22. 4.4.3 Defymed Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Defymed Automatic Insulin Dosing Device Product Portfolio
  24. 4.4.5 Defymed Recent Developments
  25. 4.5 Dexcom
  26. 4.5.1 Dexcom Company Information
  27. 4.5.2 Dexcom Business Overview
  28. 4.5.3 Dexcom Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Dexcom Automatic Insulin Dosing Device Product Portfolio
  30. 4.5.5 Dexcom Recent Developments
  31. 4.6 Insulet
  32. 4.6.1 Insulet Company Information
  33. 4.6.2 Insulet Business Overview
  34. 4.6.3 Insulet Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Insulet Automatic Insulin Dosing Device Product Portfolio
  36. 4.6.5 Insulet Recent Developments
  37. 4.7 Micro Tech Medical
  38. 4.7.1 Micro Tech Medical Company Information
  39. 4.7.2 Micro Tech Medical Business Overview
  40. 4.7.3 Micro Tech Medical Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Micro Tech Medical Automatic Insulin Dosing Device Product Portfolio
  42. 4.7.5 Micro Tech Medical Recent Developments
  43. 4.8 Tandem Diabetes Care
  44. 4.8.1 Tandem Diabetes Care Company Information
  45. 4.8.2 Tandem Diabetes Care Business Overview
  46. 4.8.3 Tandem Diabetes Care Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Tandem Diabetes Care Automatic Insulin Dosing Device Product Portfolio
  48. 4.8.5 Tandem Diabetes Care Recent Developments
  49. 4.9 Medtronic
  50. 4.9.1 Medtronic Company Information
  51. 4.9.2 Medtronic Business Overview
  52. 4.9.3 Medtronic Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Medtronic Automatic Insulin Dosing Device Product Portfolio
  54. 4.9.5 Medtronic Recent Developments
  55. 4.10 Abbott
  56. 4.10.1 Abbott Company Information
  57. 4.10.2 Abbott Business Overview
  58. 4.10.3 Abbott Automatic Insulin Dosing Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Abbott Automatic Insulin Dosing Device Product Portfolio
  60. 4.10.5 Abbott Recent Developments
5 Global Automatic Insulin Dosing Device Market Scenario by Region
  1. 5.1 Global Automatic Insulin Dosing Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Automatic Insulin Dosing Device Sales by Region: 2021-2032
  3. 5.2.1 Global Automatic Insulin Dosing Device Sales by Region: 2021-2026
  4. 5.2.2 Global Automatic Insulin Dosing Device Sales by Region: 2027-2032
  5. 5.3 Global Automatic Insulin Dosing Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Automatic Insulin Dosing Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Automatic Insulin Dosing Device Revenue by Region: 2027-2032
  8. 5.4 North America Automatic Insulin Dosing Device Market Facts & Figures by Country
  9. 5.4.1 North America Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Automatic Insulin Dosing Device Sales by Country (2021-2032)
  11. 5.4.3 North America Automatic Insulin Dosing Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Automatic Insulin Dosing Device Market Facts & Figures by Country
  16. 5.5.1 Europe Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Automatic Insulin Dosing Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Automatic Insulin Dosing Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Automatic Insulin Dosing Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Automatic Insulin Dosing Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Automatic Insulin Dosing Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Automatic Insulin Dosing Device Market Facts & Figures by Country
  41. 5.7.1 South America Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Automatic Insulin Dosing Device Sales by Country (2021-2032)
  43. 5.7.3 South America Automatic Insulin Dosing Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Automatic Insulin Dosing Device Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Automatic Insulin Dosing Device Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Automatic Insulin Dosing Device Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Automatic Insulin Dosing Device Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Automatic Insulin Dosing Device Sales by Type (2021-2032)
  2. 6.1.1 Global Automatic Insulin Dosing Device Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Automatic Insulin Dosing Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Automatic Insulin Dosing Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Automatic Insulin Dosing Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Automatic Insulin Dosing Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Automatic Insulin Dosing Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Automatic Insulin Dosing Device Sales by Application (2021-2032)
  2. 7.1.1 Global Automatic Insulin Dosing Device Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Automatic Insulin Dosing Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Automatic Insulin Dosing Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Automatic Insulin Dosing Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Automatic Insulin Dosing Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Automatic Insulin Dosing Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Automatic Insulin Dosing Device Value Chain Analysis
  2. 8.1.1 Automatic Insulin Dosing Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Automatic Insulin Dosing Device Production Mode & Process
  5. 8.2 Automatic Insulin Dosing Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Automatic Insulin Dosing Device Distributors
  8. 8.2.3 Automatic Insulin Dosing Device Customers
9 Global Automatic Insulin Dosing Device Analyzing Market Dynamics
  1. 9.1 Automatic Insulin Dosing Device Industry Trends
  2. 9.2 Automatic Insulin Dosing Device Industry Drivers
  3. 9.3 Automatic Insulin Dosing Device Industry Opportunities and Challenges
  4. 9.4 Automatic Insulin Dosing Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst